Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Profit After Tax (2016 - 2026)

Champions Oncology has reported Profit After Tax over the past 17 years, most recently at -$279000.0 for Q1 2026.

  • Quarterly results put Profit After Tax at -$279000.0 for Q1 2026, down 106.21% from a year ago — trailing twelve months through Jan 2026 was -$2.3 million (down 135.99% YoY), and the annual figure for FY2025 was $4.7 million, up 164.6%.
  • Profit After Tax for Q1 2026 was -$279000.0 at Champions Oncology, down from $268000.0 in the prior quarter.
  • Over the last five years, Profit After Tax for CSBR hit a ceiling of $4.5 million in Q1 2025 and a floor of -$2.6 million in Q3 2023.
  • Median Profit After Tax over the past 5 years was -$319000.0 (2022), compared with a mean of -$467352.9.
  • Biggest five-year swings in Profit After Tax: tumbled 12843.75% in 2023 and later soared 277.67% in 2025.
  • Champions Oncology's Profit After Tax stood at -$16000.0 in 2022, then tumbled by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then plummeted by 63.19% to $268000.0 in 2025, then tumbled by 204.1% to -$279000.0 in 2026.
  • The last three reported values for Profit After Tax were -$279000.0 (Q1 2026), $268000.0 (Q4 2025), and -$466000.0 (Q3 2025) per Business Quant data.